Kim J - Search Results

1

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry.

Koh JH, Lee Y, Kim HA, Kim J, Shin K. Koh JH, et al. Among authors: kim ha, kim j. Ther Adv Musculoskelet Dis. 2022 May 13;14:1759720X221096363. doi: 10.1177/1759720X221096363. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35586514 Free PMC article.

2

Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.

Kim J, Choi JY, Park SH, Yang SH, Park JA, Shin K, Lee EY, Kawachi H, Kohsaka H, Song YW. Kim J, et al. Arthritis Res Ther. 2014 Jun 17;16(3):R126. doi: 10.1186/ar4583. Arthritis Res Ther. 2014. PMID: 24939012 Free PMC article.

3

Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry.

Koh JH, Lee SK, Kim J, Kim HA, Shin K, Min JK. Koh JH, et al. Among authors: kim ha, kim j. Clin Exp Rheumatol. 2021 Mar-Apr;39(2):269-278. doi: 10.55563/clinexprheumatol/ftfgmf. Epub 2020 Apr 23. Clin Exp Rheumatol. 2021. PMID: 32324126 Free article.

4

The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.

Park JW, Kim MJ, Kim HA, Kim JH, Lee EB, Shin K. Park JW, et al. Front Med (Lausanne). 2022 Feb 8;9:839206. doi: 10.3389/fmed.2022.839206. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35211491 Free PMC article.

5

Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-α inhibitors and utilization of machine-learning algorithms.

Kim W, Jin Oh S, Thi Trinh N, Yeon Gil J, Ah Choi I, Hyoun Kim J, Hee Kim J, Jung JY, Kim J, Kim HA, Eun Lee K. Kim W, et al. Among authors: kim ha, kim j. Int Immunopharmacol. 2022 Oct;111:109094. doi: 10.1016/j.intimp.2022.109094. Epub 2022 Jul 29. Int Immunopharmacol. 2022. PMID: 35914450

6

Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-α inhibitors: a machine learning approach.

Kim W, Yeon HR, Kim JH, Kim JH, Kim JH, Kim HA, Jung JY, Kim J, Choi IA, Lee KE. Kim W, et al. Among authors: kim ha, kim j, kim jh. Immunol Res. 2023 Oct;71(5):709-716. doi: 10.1007/s12026-023-09382-4. Epub 2023 Apr 29. Immunol Res. 2023. PMID: 37119459

7

KOBIO, the First Web-based Korean Biologics Registry Operated With a Unified Platform Among Distinct Disease Entities.

Kim J, Koh JH, Choi SJ, Jeon CH, Kwok SK, Kim SK, Choi CB, Lee J, Lee C, Nam EJ, Park YB, Lee SS, Kim TH, Park SH, Koh EM, Yoo DH, Song YW, Kim HA, Shin K. Kim J, et al. Among authors: kim th, kim sk, kim ha. J Rheum Dis. 2021 Oct 1;28(4):176-182. doi: 10.4078/jrd.2021.28.4.176. J Rheum Dis. 2021. PMID: 37476366 Free PMC article. Review.

8

Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry.

Jung JY, Lee E, Kim JW, Suh CH, Shin K, Kim J, Kim HA. Jung JY, et al. Among authors: kim ha, kim j, kim jw. Arthritis Res Ther. 2023 Sep 19;25(1):174. doi: 10.1186/s13075-023-03165-w. Arthritis Res Ther. 2023. PMID: 37726808 Free PMC article.

9

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry.

Kim J, Kim MJ, Oh GY, Lee SK, Kim T, Shin K. Kim J, et al. Among authors: kim t, kim mj. Ther Adv Musculoskelet Dis. 2023 Oct 9;15:1759720X231201714. doi: 10.1177/1759720X231201714. eCollection 2023. Ther Adv Musculoskelet Dis. 2023. PMID: 37822329 Free PMC article.

10

Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial.

Tamai H, Ikeda K, Miyamoto T, Taguchi H, Kuo CF, Shin K, Hirata S, Okano Y, Sato S, Yasuoka H, Kuwana M, Ishii T, Kameda H, Kojima T, Taninaga T, Mori M, Miyagishi H, Sato Y, Tsai WC, Takeuchi T, Kaneko Y; MIRACLE study collaborators. Tamai H, et al. Lancet Rheumatol. 2023 Apr;5(4):e215-e224. doi: 10.1016/S2665-9913(23)00070-X. Lancet Rheumatol. 2023. PMID: 38251524 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,987 results

Search Page

Filters